Category:Cancer treatments
From WikiMD's Food, Medicine & Wellness Encyclopedia
 | Pages in this category should be moved to subcategories where applicable. This category may require frequent maintenance to avoid becoming too large. It should directly contain very few, if any, pages and should mainly contain subcategories. |
Pages in category "Cancer treatments"
The following 200 pages are in this category, out of 536 total.
(previous page) (next page)A
- A-65
- Abituzumab
- ABT-510
- Active immunotherapy
- ADE (chemotherapy)
- ADH-1
- Adjuvant therapy
- Adjuvant chemotherapy
- Adoptive immunotherapy
- ADXS11-001
- Aldesleukin
- ALK inhibitor
- Alkylating antineoplastic agents
- Alpelisib
- Alternating electric field therapy
- Altumomab pentetate
- Alvespimycin
- AMG 319
- Aminopterin sodium
- Amrubicin hydrochloride
- Andrographolide
- ANG1005
- Annamycin
- Anti-idiotypic vaccine
- Anti-VEGF
- Antiangiogenesis
- Antibody-drug conjugates
- Antibody–drug conjugate
- Antihormone therapy
- Antineoplastic activity.
- Template:Antineoplastic-agents-stub
- Antineoplastics
- Apatinib
- Aranose
- Aromatase Inhibitor
- Artificial fever
- Asparaginase erwinia chrysanthemi
- Atrasentan
- Auger therapy
- Autologous immune enhancement therapy
- Autologous tumor cell
- Avadomide
- Avapritinib
- Avicine
- AVN944
- Axalimogene filolisbac
- Axicabtagene ciloleucel
B
- Bactobolin
- Bcg vaccine
- Belantamab mafodotin
- Belapectin
- Belvarafenib
- Bemcentinib
- Bempegaldesleukin
- Berzosertib
- BI 811283
- Bi-specific T-cell engager
- Binimetinib
- Birabresib
- Bivatuzumab
- Bivatuzumab mertansine
- Bland embolization
- Boron neutron capture therapeutics
- Brachytherapy
- Brexucabtagene autoleucel
- Brigatinib
- Brivanib alaninate
C
- C-1027
- Caffeic acid phenethyl ester
- Calcium saccharate
- Camidanlumab tesirine
- Cancer Chemotherapy and Pharmacology
- Cancer drugs
- Cancer therapy
- Cantuzumab
- Capivasertib
- Capmatinib
- Capsaicin
- CAR T cell
- Carmustine
- Carmustine implant
- Carubicin
- Catumaxomab
- Cedazuridine
- Cerdulatinib
- Chemotherapy
- Chemotherapy drug
- Chimeric antigen receptor T cell
- Chromomycin a3
- Cisplatin
- Citatuzumab
- Clivatuzumab
- Clostridium novyi-NT
- Cofetuzumab pelidotin
- Coley's toxins
- Coltuximab ravtansine
- Combinatorial ablation and immunotherapy
- Combined photothermal and photodynamic therapy
- Combretastatin A-4 Phosphate
- Conbercept
- Conization
- Continuous hyperthermic peritoneal perfusion
- Cryoimmunotherapy
- Cryosurgery
- Custirsen
- Cyberknife (device)
- Cytarabine
- Cytokine-induced Killer Cell
- Cytostatic
D
- Dabrafenib
- Dacarbazine
- Dactolisib
- Dalantercept
- Dalotuzumab
- DAT (chemotherapy)
- Debulking
- Defactinib
- Demcizumab
- Dendritic cell-based cancer vaccine
- Detumomab
- Devimistat
- DHAP regimen
- Dibrospidium chloride
- Dinutuximab beta
- Discovery and development of tubulin inhibitors
- Donor lymphocyte infusion
- Dose-dense chemotherapy
- Dovitinib
- Dromostanolone propionate
- Duligotumab
- Dusigitumab
- Dynemicin a
E
- EBC-46
- Edrecolomab
- Eftilagimod alpha
- Electrochemotherapy
- Emtansine
- Enclomiphene
- Encorafenib
- Endocrine therapy
- Endoscopic mucosal resection
- Engineered CAR T cell delivery
- Entolimod
- Envafolimab
- Erlizumab
- Estrogen deprivation therapy
- Ethylnitrosourea
- Etoposide
- Etoposide phosphate
- Exagamglogene autotemcel
- Extracorporeal photopheresis
F
G
H
- Heavy ion therapy
- Hepatic arterial infusion
- Hepcortespenlisimut-L
- Hereditary condition
- Hexylresorcinol
- HIPEC
- History of cancer chemotherapy
- Hormonal antineoplastic drugs
- Hormonal therapy
- Hormonal therapy (oncology)
- HPPH
- HU-336
- Hyperfractionated radiation therapy
- Hyperthermia therapy
- Hyperthermic intraperitoneal chemotherapy
